Guangping Chen

Prof. Guangping Chen


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
XSXiang Song
Xiang Song
XQXiaoqian Qian
Xiaoqian Qian
MSMing Shen
Ming Shen
RJRong Jiang
Rong Jiang
MWMary B. Wagner
Mary B. Wagner
BSBaozhong Shen
Baozhong Shen

1 September 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GCGuangping Chen
Guangping Chen
OFOtto Fröhlich
Otto Fröhlich
YYYuan Yang
Yuan Yang
JKJanet D. Klein
Janet D. Klein
JSJeff M. Sands
Jeff M. Sands
The vasopressin-regulated urea transporter (UT)-A1 is a transmembrane protein with two glycosylated forms of 97 and 117 kDa; both are derived from a single 88-kDa core protein. However, the precise molecular sites and the function for UT-A1 N-glycosylation are not known. In this study, we compared Madin-Darby canine kidney cells stably expressing wild-type (WT) UT-A1 to Madin-Darby canine kidney cell lines stably expressing mutant UT-A1 lacking one (A1m1, A1m2) or both glycosylation sites (m1m2). Site-directed mutagenesis revealed that UT-A1 has two glycosylation sites at Asn-279 and -742. Urea flux is stimulated by 10 nm vasopressin (AVP) or 10 μm forskolin (FSK) in WT cells. In contrast, m1m2 cells have a delayed and significantly reduced maximal urea flux. A 15-min treatment with AVP and FSK significantly increased UT-A1 cell surface expression in WT but not in m1m2 cells, as measured by biotinylation. We confirmed this finding using immunostaining. Membrane fractionation of the plasma membrane, Golgi, and endoplasmic reticulum revealed that AVP or FSK treatment increases UT-A1 abundance in both Golgi and plasma membrane compartments in WT but not in m1m2 cells. Pulse-chase experiments showed that UT-A1 half-life is reduced in m1m2 cells compared with WT cells. Our results suggest that mutation of the N-linked glycosylation sites reduces urea flux by reducing UT-A1 half-life and decreasing its accumulation in the apical plasma membrane. In vivo, inner medullary collecting duct cells may regulate urea uptake by altering UT-A1 glycosylation in response to AVP stimulation.

1 January 2012 in Frontiers in Physiology
Verified
Journal Article
Open access
XLXuechen Li
Xuechen Li
GCGuangping Chen
Guangping Chen
YBYang Baoxue
Yang Baoxue
In mammals, there are two types of urea transporters; urea transporter (UT)-A and UT-B. The UT-A transporters are mainly expressed in kidney epithelial cells while UT-B demonstrates a broader distribution in kidney, heart, brain, testis, urinary tract, and other tissues. Over the past few years, multiple urea transporter knockout mouse models have been generated enabling us to explore the physiological roles of the different urea transporters. In the kidney, deletion of UT-A1/UT-A3 results in polyuria and a severe urine concentrating defect, indicating that intrarenal recycling of urea plays a crucial role in the overall capacity to concentrate urine. Since UT-B has a wide tissue distribution, multiple phenotypic abnormalities have been found in UT-B null mice, such as defective urine concentration, exacerbated heart blockage with aging, depression-like behavior, and earlier male sexual maturation. This review summarizes the new insights of urea transporter functions in different organs, gleaned from studies of urea transporter knockout mice, and explores some of the potential pharmacological prospects of urea transporters.

29 September 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
GCGuangping Chen
Guangping Chen
AHAshley G. Howe
Ashley G. Howe
GXGang Xu
Gang Xu
OFOtto Fröhlich
Otto Fröhlich
JKJanet D. Klein
Janet D. Klein
JSJeff M. Sands
Jeff M. Sands
The UT‐A1 urea transporter is a glycoprotein with two different glycosylated forms of 97 and 117 kDa. In this study, we found the 117‐kDa UT‐A1 preferentially resides in lipid rafts, suggesting that the glycosylation status may interfere with UT‐A1 lipid raft trafficking. This was confirmed by a site‐directed mutagenesis study in MDCK cells. The nonglycosylated UT‐A1 showed reduced localization in lipid rafts. By using sugar‐specific binding lectins, we further found that the UT‐A1 in nonlipid rafts contained a high amount of mannose, as detected by concanavalin A, while the UT‐A1 in lipid rafts was the mature N ‐acetylglucosamine‐containing form, as detected by wheat germ agglutinin. In the inner medulla (IM) of diabetic rats, the more abundant 117‐kDa UT‐A1 in lipid rafts was the mature glycosylation form, with high amounts of N ‐acetylglucosamine and sialic acid. In contrast, in the IM of normal rats, the predominant 97‐kDa UT‐A1 was the form enriched in mannose. Functionally, inhibition of glycosylation by tunicamycin or elimination of the glycosylation sites by mutation significantly reduced UT‐A1 activity in oocytes. Taken together, our study reveals a new role of N ‐linked glycosylation in regulating UT‐A1 activity by promoting UT‐A1 trafficking into membrane lipid raft subdomains.—Chen, G., Howe, A. G., Xu, G., Fröhlich, O., Klein, J. D., Sands, J. M. Mature N ‐linked glycans facilitate UT‐A1 urea transporter lipid raft compartmentalization. FASEB J. 25, 4531–4539 (2011). www.fasebj.org

1 November 2008 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
GCGuangping Chen
Guangping Chen
HHHaidong Huang
Haidong Huang
OFOtto Fröhlich
Otto Fröhlich
YYYuan Yang
Yuan Yang
JKJanet D. Klein
Janet D. Klein
JSJeff M. Sands
Jeff M. Sands
UT-A1 is the primary urea transporter in the apical plasma membrane responsible for urea reabsorption in the inner medullary collecting duct. Although the physiological function of UT-A1 has been well established, the molecular mechanisms that regulate its activity are less well understood. Analysis of the UT-A1 amino acid sequence revealed a potential MDM2 E3 ubiquitin ligase-binding motif in the large intracellular loop of UT-A1, suggesting that UT-A1 urea transporter protein may be regulated by the ubiquitin-proteasome pathway. Here, we report that UT-A1 is ubiquitinated and degraded by the proteasome but not the lysosome proteolytic pathway. Inhibition of proteasome activity causes UT-A1 cell surface accumulation and concomitantly increases urea transport activity. UT-A1 interacts directly with MDM2; the binding site is located in the NH2-terminal p53-binding region of MDM2. MDM2 mediates UT-A1 ubiquitination both in vivo and in vitro. Overexpression of MDM2 promotes UT-A1 degradation. The mechanism is likely to be physiologically important as UT-A1 ubiquitination was identified in kidney inner medullary tissue. The ubiquitin-proteasome degradation pathway provides an important novel mechanism for UT-A1 regulation.

1 June 2009 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
XFXiuyan Feng
Xiuyan Feng
HHHaidong Huang
Haidong Huang
YYYuan Yang
Yuan Yang
OFOtto Fröhlich
Otto Fröhlich
JKJanet D. Klein
Janet D. Klein
GCGuangping Chen
Guangping Chen
The cell plasma membrane contains specialized microdomains called lipid rafts which contain high amounts of sphingolipids and cholesterol. Lipid rafts are involved in a number of membrane protein functions. The urea transporter UT-A1, located in the kidney inner medullary collecting duct (IMCD), is important for urine concentrating ability. In this study, we investigated the possible role of lipid rafts in UT-A1 membrane regulation. Using sucrose gradient cell fractionation, we demonstrated that UT-A1 is concentrated in the caveolae-rich fraction both in stably expressing UT-A1 HEK293 cells and in freshly isolated kidney IMCD suspensions. In these gradients, UT-A1 at the cell plasma membrane is codistributed with caveolin-1, a major component of caveolae. The colocalization of UT-A1 in lipid rafts/caveolae was further confirmed in isolated caveolae from UT-A1-HEK293 cells. The direct association of UT-A1 and caveolin-1 was identified by immunoprecipitation and GST pull-down assay. Examination of internalized UT-A1 in pEGFP-UT-A1 transfected HEK293 cells fluorescent overlap with labeled cholera toxin subunit B, a marker of the caveolae-mediated endocytosis pathway. Disruption of lipid rafts by methyl-β-cyclodextrin or knocking down caveolin-1 by small-interference RNA resulted in UT-A1 cell membrane accumulation. Functionally, overexpression of caveolin-1 in oocytes decreased UT-A1 urea transport activity and UT-A1 cell surface expression. Our results indicate that lipid rafts/caveolae participate in UT-A1 membrane regulation and this effect is mediated via a direct interaction of caveolin-1 with UT-A1.